A. Sanders
Patrimonio netto: 1 M $ in data 30/06/2026
Patrimonio netto: 1 M $ in data 30/06/2026
A. Machelle Sanders currently serves as Independent Director at BioCryst Pharmaceuticals, Inc. since 2022, Independent Director at Fortrea Holdings, Inc. since 2024, and Secretary at The North Carolina Department of Commerce since 2021.
Former roles include Independent Director at Radius Health, Inc. from 2021 to 2022, Independent Director at NVN Liquidation, Inc. from 2017 to 2023, Director at The North Carolina Biotechnology Center from 2013 to 2015, Director at NVN Liquidation, Inc. from 2017 to 2024, Secretary at North Carolina Department of Administration from 2017 to 2021, Vice President-Manufacturing & General Manager at Research Triangle Park, and VP-Multiple Sclerosis Franchise Product Operations at Biogen, Inc. from 2015 to 2016.
Education includes undergraduate studies at North Carolina State University and graduate studies at Pfeiffer University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 46.099 ( 0,05% ) | 802 123 $ | 30/06/2026 | |
| 11/06/2026 | 45.936 ( 0,02% ) | 459 360 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 08/02/2022 |
| FORTREA HOLDINGS INC. | Direttore/Membro del Consiglio | 14/05/2024 |
The North Carolina Department of Commerce
The North Carolina Department of Commerce General GovernmentGovernment State department | Segretario Aziendale | 01/02/2021 |
| Società | Posizione | Fine |
|---|---|---|
| NVN LIQUIDATION, INC. | Direttore/Membro del Consiglio | 01/04/2024 |
| NVN LIQUIDATION, INC. | Direttore/Membro del Consiglio | 27/09/2023 |
| RADIUS HEALTH, INC. | Direttore/Membro del Consiglio | 15/08/2022 |
North Carolina Department of Administration
North Carolina Department of Administration General GovernmentGovernment Manages the financial, human and other resources of the state | Segretario Aziendale | 01/02/2021 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
NVN Liquidation, Inc.
NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfeiffer University
Pfeiffer University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Technology Services |
The North Carolina Department of Commerce
The North Carolina Department of Commerce General GovernmentGovernment State department | Government |
North Carolina Department of Administration
North Carolina Department of Administration General GovernmentGovernment Manages the financial, human and other resources of the state | Government |
Research Triangle Park | |
Fortrea Holdings, Inc.
Fortrea Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale